These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo. Steitz J; Brück J; Lenz J; Büchs S; Tüting T J Invest Dermatol; 2005 Jan; 124(1):144-50. PubMed ID: 15654968 [TBL] [Abstract][Full Text] [Related]
3. The control of CD8+ T cell responses is preserved in perforin-deficient mice and released by depletion of CD4+CD25+ regulatory T cells. Ataera H; Simkins HM; Hyde E; Yang J; Hermans IF; Petersen TR; Ronchese F J Leukoc Biol; 2013 Oct; 94(4):825-33. PubMed ID: 23883515 [TBL] [Abstract][Full Text] [Related]
5. Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo. You S; Cho YH; Byun JS; Shin EC Clin Exp Immunol; 2013 Oct; 174(1):38-44. PubMed ID: 23711243 [TBL] [Abstract][Full Text] [Related]
6. A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model. McWilliams JA; McGurran SM; Dow SW; Slansky JE; Kedl RM J Immunol; 2006 Jul; 177(1):155-61. PubMed ID: 16785510 [TBL] [Abstract][Full Text] [Related]
7. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation. Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973 [TBL] [Abstract][Full Text] [Related]
8. Engagement of NK receptor NKG2D, but not 2B4, results in self-reactive CD8+ T cells and autoimmune vitiligo. Zloza A; Lyons GE; Chlewicki LK; Kohlhapp FJ; O'Sullivan JA; Lacek AT; Moore TV; Jagoda MC; Kumar V; Guevara-Patiño JA Autoimmunity; 2011 Dec; 44(8):599-606. PubMed ID: 21913803 [TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus-based cancer vaccines expressing TRP2 induce rejection of melanoma in mice. Xu G; Smith T; Grey F; Hill AB Biochem Biophys Res Commun; 2013 Jul; 437(2):287-91. PubMed ID: 23811402 [TBL] [Abstract][Full Text] [Related]
10. Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma. Steitz J; Brück J; Steinbrink K; Enk A; Knop J; Tüting T Int J Cancer; 2000 Apr; 86(1):89-94. PubMed ID: 10728600 [TBL] [Abstract][Full Text] [Related]
11. Maintenance of immune hyporesponsiveness to melanosomal proteins by DHICA-mediated antioxidation: Possible implications for autoimmune vitiligo. Liu XM; Zhou Q; Xu SZ; Wakamatsu K; Lei TC Free Radic Biol Med; 2011 May; 50(9):1177-85. PubMed ID: 21256957 [TBL] [Abstract][Full Text] [Related]
12. Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity. Avogadri F; Merghoub T; Maughan MF; Hirschhorn-Cymerman D; Morris J; Ritter E; Olmsted R; Houghton AN; Wolchok JD PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844763 [TBL] [Abstract][Full Text] [Related]
13. Synthetic TRP2 long-peptide and α-galactosylceramide formulated into cationic liposomes elicit CD8+ T-cell responses and prevent tumour progression. Neumann S; Young K; Compton B; Anderson R; Painter G; Hook S Vaccine; 2015 Oct; 33(43):5838-5844. PubMed ID: 26363382 [TBL] [Abstract][Full Text] [Related]
14. Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy. Snook AE; Magee MS; Schulz S; Waldman SA Eur J Immunol; 2014 Jul; 44(7):1956-66. PubMed ID: 24771148 [TBL] [Abstract][Full Text] [Related]
15. Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma. Byrne KT; Côté AL; Zhang P; Steinberg SM; Guo Y; Allie R; Zhang W; Ernstoff MS; Usherwood EJ; Turk MJ J Clin Invest; 2011 May; 121(5):1797-809. PubMed ID: 21540555 [TBL] [Abstract][Full Text] [Related]
16. Expansion of regulatory CD8+ CD25+ T cells after neonatal alloimmunization. Adams B; Dubois A; Delbauve S; Debock I; Lhommé F; Goldman M; Flamand V Clin Exp Immunol; 2011 Mar; 163(3):354-61. PubMed ID: 21175595 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of dendritic cells loaded with a fusion mRNA encoding tyrosinase-related protein 2 and enhanced green fluorescence protein on B16 melanoma. Fukui M; Nakano-Hashimoto T; Okano K; Maruta Y; Suehiro Y; Hamanaka Y; Yamashita H; Imai K; Kawano MM; Hinoda Y Tumour Biol; 2004; 25(5-6):252-7. PubMed ID: 15627888 [TBL] [Abstract][Full Text] [Related]
18. Neuropilin-1 expression is induced on tolerant self-reactive CD8+ T cells but is dispensable for the tolerant phenotype. Jackson SR; Berrien-Elliott M; Yuan J; Hsueh EC; Teague RM PLoS One; 2014; 9(10):e110707. PubMed ID: 25343644 [TBL] [Abstract][Full Text] [Related]
19. Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Kalia V; Sarkar S; Subramaniam S; Haining WN; Smith KA; Ahmed R Immunity; 2010 Jan; 32(1):91-103. PubMed ID: 20096608 [TBL] [Abstract][Full Text] [Related]
20. Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo. Steitz J; Wenzel J; Gaffal E; Tüting T Eur J Cell Biol; 2004 Dec; 83(11-12):797-803. PubMed ID: 15679123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]